Skip to main content
. 2022 Mar 30;14(7):1763. doi: 10.3390/cancers14071763
AMP adenosin monophosphate
ATP adenosintriphosphat
CLD7 Claudin 7
CSS cancer-specific survival
ccRCC clear cell renal cell carcinoma
chRCC chromophobe renal cell carcinoma
cGAMP cyclic guanosine monophosphate-adenosin monophosphate
cGMP cyclic Guanosinmonophosphate
cGAS cyclic guanosine monophosphate-adenosin monophosphate synthase
CTLA-4 cytotoxic T-lymphocyte-associated protein 4
FFPE formalin-fixed paraffin-embedded
FT-ICR Fourier-transform ion cyclotron resonance
GMP guanosin monophosphate
GTP guanosintriphosphate
IFN interferon
IkB or IKK IkappaB kinase
IRF3 interferon regulatory factor 3
ISUP International Society of Urological Pathology
KM Kaplan–Meier
MALDI High mass resolution matrix-assisted laser desorption/ionization
MET mesenchymal–epithelial transition factor
MSI mass spectrometry imaging
NF-κB nuclear factor kappa B
OS overall survival
PD-1 programmed death 1
PD-L1 programmed Death-Ligand 1
pRCC papillary renal cell carcinoma
PFS progression free survival
RMC renal medullary carcinoma
rO renal oncocytoma
STING stimulator of interferon genes
TBK1 Tank-binding kinase 1
TNFα tumor necrosis factor α
TMA tissue microarray
WHO World Health Organization